Tilt-Table Test: Diagnosing Syncope When the Event Is Gone

The Scene

The following scene is drawn from the composite of patients I have cared for in clinic and on the hospital floor. All identifying details are changed.

She described it the same way most patients with vasovagal syncope describe it, which is to say she described a sequence of events so consistent and recognizable that the diagnosis was nearly complete before any test was ordered. She had been standing in a long line at the grocery store on a warm afternoon. She noticed a wave of nausea, then a narrowing of her vision as though someone were closing the curtains from the edges inward. Her hearing became distant and muffled. She sat down on the floor just before she lost consciousness. Her husband said she was out for no more than thirty seconds. She woke up pale and sweaty and nauseous, and felt exhausted for the rest of the day.

This was her third episode. All three occurred in situations of prolonged standing, heat, or emotional stress. No palpitations beforehand. No chest pain. No incontinence. No tongue biting. No confusion afterward. She was twenty-nine years old, no cardiac history, normal ECG, normal echocardiogram.

The clinical picture is textbook vasovagal syncope. So why order a tilt-table test?

In her case, the test was not ordered to make the diagnosis, which the history had already established. It was ordered because she worked as a surgical scrub technician. Her employer required documentation of a diagnosis before modifying her work restrictions. The tilt-table test provided that documentation.

This is one legitimate use. But the tilt-table test is also ordered in less straightforward situations: the patient who loses consciousness without the typical prodrome, where the differential includes cardiac arrhythmia or seizure; the patient with recurrent falls and no witnesses where orthostatic hypotension and vasovagal mechanisms need to be separated; the patient with fatigue, cognitive fog, and exercise intolerance who has been diagnosed with postural orthostatic tachycardia syndrome (POTS) by symptom criteria but needs hemodynamic confirmation; and the patient with a prior cardiac implant where pacemaker therapy for recurrent syncope is being considered and the ISSUE-3 trial data are relevant.

The tilt-table test is a provocative study that exposes the cardiovascular response to orthostatic stress under controlled conditions. It does not diagnose cardiac arrhythmia. It does not diagnose epilepsy. What it does is reproduce the hemodynamic substrate of neurocardiogenic or dysautonomic syncope in the laboratory, in a controlled setting, in a patient who has already recovered from the original event.

At Carle Foundation Hospital in Urbana-Champaign, the tilt-table test is performed in the cardiac catheterization laboratory or a dedicated autonomic physiology suite, with continuous hemodynamic monitoring and resuscitation capability.

What It Is

The tilt-table test is a provocative diagnostic study that uses passive upright tilt to induce orthostatic stress and evaluate the autonomic cardiovascular response. The patient is placed on a motorized table equipped with a footrest and safety straps, and the table is tilted from horizontal to a 60 to 80-degree upright angle while heart rate, blood pressure, and symptoms are continuously monitored.

What it provokes: In the upright position, approximately 300 to 800 mL of blood pools in the lower extremity and splanchnic venous circulation due to gravity. In a normally functioning autonomic nervous system, this venous pooling is sensed by baroreceptors, and a reflex sympathetic response increases heart rate, peripheral vascular resistance, and myocardial contractility to maintain cardiac output and blood pressure. The upright tilt test accentuates this venous pooling beyond what most patients experience in daily life, providing a controlled orthostatic challenge.

What it detects:

• Vasovagal syncope (neurocardiogenic syncope): An abnormal reflex response to the orthostatic challenge in which paradoxical sympathetic withdrawal and vagal activation produce bradycardia, vasodilation, or both, causing syncope or near-syncope. The Bezold-Jarisch reflex, triggered by reduced ventricular filling and vigorous contraction, is one proposed mechanism.
• Orthostatic hypotension: A drop in systolic blood pressure of 20 mmHg or diastolic blood pressure of 10 mmHg within 3 minutes of assuming the upright position, due to inadequate autonomic response. Classical orthostatic hypotension is common in elderly patients, autonomic neuropathy (diabetic, Parkinson’s disease), hypovolemia, and certain medications.
• Postural orthostatic tachycardia syndrome (POTS): A sustained heart rate increase of 30 bpm or more (or to above 120 bpm) within 10 minutes of assuming the upright position, in the absence of orthostatic hypotension, accompanied by orthostatic symptoms.
• Psychogenic pseudosyncope: Loss of responsiveness without hemodynamic change during tilt, suggesting a non-cardiac, non-autonomic mechanism.

Types of tilt test:

Passive tilt: Table tilted to 60 to 80 degrees for 20 to 45 minutes without pharmacologic provocation. Specificity is high but sensitivity is modest (20 to 50 percent).

Provoked tilt with isoproterenol: Low-dose isoproterenol infusion is titrated during the upright tilt phase to augment sympathetic stimulation. Increases sensitivity but reduces specificity; less commonly used now.

Provoked tilt with nitroglycerin: Sublingual nitroglycerin (0.3 to 0.4 mg) administered after 20 minutes of passive tilt without syncope. Venodilation augments venous pooling and lowers cardiac filling pressure. This is the most widely used provocation protocol in Europe and is incorporated into the Italian Protocol. It increases sensitivity without the arrhythmic risk of isoproterenol 5 / Solid .

The Mechanism

Normal orthostatic physiology: When a person stands from supine, 500 to 700 mL of blood redistributes to the lower extremities and abdomen within seconds. Central venous return falls. Stroke volume decreases. Cardiac output drops transiently. Arterial baroreceptors in the carotid sinus and aortic arch detect the resulting pressure decrease and activate sympathetic outflow through brainstem autonomic nuclei. This produces:

• Increased heart rate (chronotropic effect)
• Increased contractility (inotropic effect)
• Increased peripheral vascular resistance (vasoconstrictive effect)
• Release of norepinephrine, vasopressin, and activation of the renin-angiotensin system for sustained pressure maintenance

Within 20 to 30 seconds, blood pressure is restored to near-baseline. The person feels nothing.

Vasovagal physiology: In susceptible individuals, the initial sympathetic response to orthostasis is exaggerated. The heart contracts more vigorously against a relatively underfilled ventricle. This vigorous contraction of an underfilled chamber is sensed by ventricular mechanoreceptors (C-fiber afferents, also called Bezold-Jarisch receptors), which generate a paradoxical inhibitory signal. The result is a sudden withdrawal of sympathetic tone and a surge in vagal efferent activity, producing:

• Bradycardia (cardioinhibitory component): heart rate may drop to 30 to 40 bpm
• Vasodilation (vasodepressor component): systemic vascular resistance falls
• Or both simultaneously (mixed response)

Blood pressure and cerebral perfusion pressure fall rapidly. Consciousness is lost within seconds of cerebral perfusion falling below the threshold of 30 to 40 mmHg. The event is brief because the horizontal posture (achieved when the patient falls or is lowered) immediately restores venous return and terminates the reflex.

POTS physiology: POTS involves sustained orthostatic tachycardia without syncope and without adequate orthostatic vasoconstriction to explain the tachycardia as a compensatory response. Multiple mechanisms contribute to POTS: low circulating blood volume (hypovolemic POTS), impaired peripheral vasoconstriction with compensatory tachycardia (neuropathic POTS), hyperadrenergic state with excessive sympathetic activation, mast cell activation, and, increasingly recognized, autoimmune mechanisms including anti-adrenergic receptor antibodies 3 / Early .

Orthostatic hypotension physiology: Classical orthostatic hypotension reflects failure of the vasoconstrictor reflex to maintain blood pressure in the upright position. The baroreceptor senses the pressure drop. The sympathetic output to the peripheral vasculature is impaired: either from peripheral autonomic neuropathy (diabetic autonomic neuropathy, multisystem atrophy), central autonomic dysfunction (Parkinson’s disease, pure autonomic failure), volume depletion, or medications (alpha-blockers, vasodilators, diuretics). The pressure drop is sustained, not transient.

How It Is Used

When to order the tilt test:

Confirmed appropriate indications:

• Recurrent unexplained syncope in the absence of structural heart disease or a primary arrhythmic cause, when the diagnosis will change management 5 / Solid
• Single syncope episode with clinical injury or occupational risk (pilot, surgeon, bus driver) where documentation is required
• Suspected POTS with hemodynamic confirmation needed for treatment planning
• Differentiation of orthostatic hypotension subtypes (classical, delayed, initial) to guide treatment

Lower-yield situations:

• Typical vasovagal syncope with clear diagnosis by history and no management implication from the test
• Known cardiac cause of syncope already identified (arrhythmia, structural disease)
• Evaluation of seizure disorder (tilt table cannot diagnose epilepsy, though it may identify psychogenic pseudosyncope)

Test protocol (standard):

1. Patient fasts for 3 hours before the test
2. Two peripheral IV lines placed (one for infusion if provocation is planned; one as backup)
3. Continuous 12-lead ECG, blood pressure every 1 to 2 minutes (or continuously by finger plethysmography), pulse oximetry
4. Supine baseline for 20 minutes
5. Tilt to 60 to 70 degrees for 20 to 45 minutes (passive phase)
6. If no response in passive phase, sublingual nitroglycerin 0.4 mg or isoproterenol infusion for provocation (protocol-dependent)
7. Monitor for 15 minutes post-provocation in upright position
8. If syncope or near-syncope occurs, return table to horizontal immediately; atropine available for severe cardioinhibitory responses

Response classification (VASIS criteria):

• Type 1 (Mixed): Heart rate less than 40 bpm for less than 10 seconds, or brief asystole less than 3 seconds; blood pressure falls before heart rate
• Type 2A (Cardioinhibitory without asystole): Heart rate less than 40 bpm for more than 10 seconds; no asystole more than 3 seconds; blood pressure falls before or simultaneously with heart rate
• Type 2B (Cardioinhibitory with asystole): Asystole more than 3 seconds; blood pressure falls coincidentally
• Type 3 (Vasodepressor): Heart rate decrease less than 10 percent; blood pressure falls

This classification guides the discussion of pacemaker therapy: only Type 2B (asystole-predominant response) has meaningful benefit from pacemaker implantation.

The Evidence

Diagnostic Performance

The diagnostic yield of passive tilt testing for vasovagal syncope ranges from 26 to 87 percent across studies, reflecting heterogeneous protocols and patient populations. The highly variable sensitivity is the primary limitation. A negative tilt table test does not exclude vasovagal syncope. A positive test (syncope reproduced on the table with appropriate hemodynamic pattern) confirms the diagnosis 5 / Solid .

Specificity of passive tilt for vasovagal syncope is approximately 90 percent. With nitroglycerin provocation, sensitivity increases to 50 to 70 percent, and specificity decreases slightly to approximately 85 percent. Isoproterenol provocation has higher sensitivity but lower specificity (70 to 85 percent), with additional risk of inducing arrhythmia 5 / Solid .

The reproducibility of tilt-table testing is modest. A positive test can be reproduced on repeat testing in only 65 to 85 percent of cases. A negative test is less useful than a positive one. The test is most informative when it reproduces the patient’s symptoms with an accompanying hemodynamic change that explains the clinical event.

ISSUE-3 Trial (International Study on Syncope of Uncertain Etiology 3)

The ISSUE-3 trial addressed the question of whether pacemaker implantation reduces syncope recurrence in patients with cardioinhibitory vasovagal syncope documented by implantable loop recorder (ILR). This trial is directly relevant to the tilt-table test because it clarified when the hemodynamic response pattern guides device therapy.

ISSUE-3 enrolled 77 patients age 40 or older with three or more syncope episodes, documented asystole on ILR during a spontaneous episode, and confirmed cardioinhibitory response on tilt-table test. Patients were randomized to pacing-activated dual-chamber pacemaker versus sensing-only device (sham pacing) 5 / Solid .

Results:

• Two-year syncope recurrence: 25 percent in pacing group vs 57 percent in control group
• Hazard ratio: 0.37 (95% CI 0.15 to 0.90; p = 0.028)
• Absolute risk reduction: 32 percent
• Number needed to treat: approximately 3 patients

This trial established a role for pacemaker therapy in selected patients with recurrent vasovagal syncope who are older (not young patients where the mechanism is reversible) and who have documented asystole on monitoring during a spontaneous episode. The tilt-table test alone, without ILR documentation of spontaneous events, is insufficient to select patients for pacemaker implantation.

The implication for clinical practice: the tilt-table test identifies the cardioinhibitory pattern (asystole-predominant, Type 2B), but the treatment decision requires ILR documentation of asystole during a natural event. The tilt-table response predicts the spontaneous event mechanism but does not substitute for spontaneous event monitoring.

POTS Diagnostic Criteria

The consensus criteria for POTS require a heart rate increase of at least 30 bpm within 10 minutes of upright tilt (or 40 bpm in patients aged 12 to 19), reaching a heart rate of at least 120 bpm, in the absence of orthostatic hypotension and in the presence of orthostatic symptoms for more than 6 months 5 / Solid . Tilt-table testing with continuous heart rate monitoring is the standard method for confirming hemodynamic POTS, though a simpler 10-minute standing test (NASA lean test) has been validated as an alternative in some protocols 4 / Promising .

Sensitivity-Specificity Trade-Off

The fundamental limitation of the tilt-table test is its diagnostic performance in unselected populations. A meta-analysis of 28 studies with passive tilt testing reported a mean sensitivity of 56 percent and specificity of 92 percent for vasovagal syncope 5 / Solid . The test is most valuable as a confirmatory tool when clinical suspicion is high, not as a screening tool applied broadly to all patients with unexplained syncope.

The Patient Experience

Before the Test

The test requires fasting for at least 3 hours (typically 4 to 6 hours) before the procedure. Caffeine, beta-blockers, and certain vasoactive medications may be held the morning of the test depending on the clinical indication. Patients should dress comfortably, as they will be in a gown on the tilt table for 45 to 90 minutes.

Most patients are anxious about a test that is specifically designed to make them faint. A few minutes of direct explanation before the procedure begins is time well spent: if the test works as intended, you will feel the same symptoms you described, and the moment you tell us or we see the hemodynamic change, the table goes immediately horizontal and you will recover within 20 to 30 seconds. The worst outcome is the one we are there to reproduce. It is controlled, monitored, and reversible.

During the Test

The passive phase is unremarkable for most patients. Twenty minutes of lying on a tilted table while attached to monitors. Some patients feel mildly lightheaded. Some feel nothing. Patients are asked to avoid voluntary movements of the legs, which would activate the muscle pump and confound the venous pooling effect.

If nitroglycerin provocation is used, the sublingual spray or tablet causes a transient headache and warm flush within 60 to 90 seconds. Patients are warned in advance.

If a vasovagal response occurs, the progression from prodrome to syncope typically takes 30 to 90 seconds: first nausea, then peripheral vision narrowing, then auditory muffling, then pallor and diaphoresis, then loss of consciousness or near-loss. The table is immediately lowered. Atropine 0.5 to 1 mg IV is available for bradycardia requiring treatment, though most vasovagal responses resolve spontaneously within seconds of returning to horizontal.

What Your Cardiologist Will Not Have Time to Explain

• A positive tilt-table test means the test reproduced your syncope or near-syncope with an accompanying hemodynamic change. It confirms the diagnosis. It does not predict exactly when your next episode will occur or how severe it will be.
• A negative tilt-table test does not mean you do not have vasovagal syncope. It means the test did not reproduce the event during this 45-to-90-minute window. The diagnosis can still be made clinically if the history is compelling.
• POTS diagnosis from the tilt-table test means a persistent heart rate increase during upright posture. The treatment is not straightforward. It involves lifestyle modifications (high salt and fluid intake, compression garments, graded exercise), sometimes pharmacologic therapy (fludrocortisone, midodrine, beta-blockers, ivabradine), and in some cases investigation of autoimmune or mast cell mechanisms.

Sex Differences

Vasovagal syncope is the most common cause of syncope across all age groups, but its prevalence is somewhat higher in young women, who also have higher rates of POTS. POTS affects women approximately four to five times more often than men, predominantly in the reproductive years 5 / Solid . The mechanisms in women may involve differences in blood volume regulation (influenced by estrogen and the menstrual cycle), lower absolute blood volume, and sex-specific autoimmune predispositions. Symptoms of POTS overlap substantially with those of anxiety, chronic fatigue, and fibromyalgia, leading to underdiagnosis and misdiagnosis in women who present with these symptom complexes. When a young woman presents with chronic fatigue, brain fog, palpitations with standing, and exercise intolerance, orthostatic hemodynamic testing with tilt-table or a 10-minute standing test should be performed before the symptoms are attributed entirely to anxiety or deconditioning 4 / Promising .

Geographic Access in Illinois

Tilt-table testing requires a dedicated motorized table with appropriate continuous hemodynamic monitoring equipment and trained personnel who can manage a syncopal event. The test is not available at every hospital. In the Urbana-Champaign area, Carle Foundation Hospital performs tilt-table testing in the cardiac catheterization laboratory. The University of Illinois Health cardiac electrophysiology program performs complete autonomic testing including tilt-table, with subspecialty availability for complex dysautonomia evaluation. Northwestern Medicine Bluhm Cardiovascular Institute and Rush University Medical Center both operate formal autonomic function programs for complex POTS and dysautonomia cases requiring multi-specialty coordination.

Decisions and Trade-Offs

The Management Implications of a Positive Test

A positive vasovagal response on tilt-table testing changes management primarily by confirming the diagnosis and directing the treatment strategy:

Lifestyle modifications (first-line for all patients):

• Avoidance of precipitating triggers: prolonged standing in warm environments, dehydration, alcohol
• Physical counterpressure maneuvers during prodrome: leg crossing with tensing, squatting, hand grip and arm tensing
• Increased fluid intake (2 to 3 liters per day) and salt intake if not contraindicated by hypertension
• Graded isotonic exercise to improve lower extremity muscle pump function

Pharmacologic options:

• Midodrine (alpha-1 agonist, vasoconstrictor): reduces syncope recurrence in patients with vasodepressor-predominant responses 4 / Promising
• Fludrocortisone (mineralocorticoid, expands intravascular volume): commonly used in young patients with vasovagal syncope and POTS 3 / Early
• Beta-blockers: older data suggested benefit; more recent RCT data from the POST trial showed no benefit over placebo (Unsupported, Sheldon, Circulation. 2006; doi:10.1161/CIRCULATIONAHA.105.567150)
• SSRIs: some evidence in highly recurrent vasovagal syncope 3 / Early 90095-7)

Pacemaker implantation: Only for selected patients with recurrent syncope, age 40 or older, and documented spontaneous asystole on ILR. Tilt-table cardioinhibitory response alone is insufficient to justify pacemaker implantation in most patients 5 / Solid .

Differentiating Vasovagal Syncope from Orthostatic Hypotension

These two diagnoses have different treatment strategies and different long-term implications. The distinction on tilt-table testing is straightforward:

• Vasovagal syncope: blood pressure and heart rate are maintained during the first few minutes of tilt, then an abrupt reflex-mediated fall occurs, typically with associated prodromal symptoms
• Orthostatic hypotension: blood pressure falls progressively from the moment of tilting, within the first 3 minutes, without the late reflex-mediated component

Orthostatic hypotension requires investigation of its cause (autonomic neuropathy, volume depletion, medications) rather than the vasovagal management strategy. The tilt-table test provides the hemodynamic time course that separates these diagnoses.

POTS Versus Inappropriate Sinus Tachycardia

A persistent heart rate increase on tilt testing may represent POTS (orthostatic tachycardia with symptoms) or inappropriate sinus tachycardia (increased resting heart rate with symptoms, which may worsen with standing). The distinction matters because inappropriate sinus tachycardia is present at rest and does not require upright posture to manifest, whereas POTS is specifically triggered by the orthostatic position. Both are more common in young women, and both may respond to similar therapies including beta-blockers and ivabradine 4 / Promising . Tilt-table testing confirms the orthostatic character of the tachycardia in POTS.

The Three Questions Every Patient Should Ask

1. “If the test is negative, does that mean my syncope was not vasovagal?” No. The tilt-table test has modest sensitivity (50 to 70 percent depending on protocol). A negative test in a patient with a compelling history of vasovagal syncope does not change the clinical diagnosis. Management decisions should be based on the clinical history and the impact of recurrences on quality of life and safety, not solely on the tilt-table result.

2. “What does it mean if my heart rate drops very low on the table?” A cardioinhibitory response (heart rate falling below 40 or asystole lasting more than 3 seconds) identifies patients who may benefit from pacemaker evaluation if syncope recurs and is documented to be asystole-predominant on a prolonged cardiac monitor. Ask whether the cardioinhibitory pattern makes you a candidate for implantable loop recorder monitoring.

3. “I have been told I have POTS. What are the treatment options beyond water and salt?” POTS treatment is stratified. First-line: volume expansion (salt, fluid, compression garments), graded exercise program. Second-line: pharmacologic (fludrocortisone, midodrine, beta-blockers, ivabradine). For hyperadrenergic POTS: clonidine or low-dose propranolol. For autoimmune POTS: investigation for treatable autoimmune triggers. Ask for a referral to a center with a formal POTS program if first-line measures fail.

Clinical Synthesis

Syncope is the third most common reason for emergency department visits in the United States, generating a diagnostic odyssey that frequently ends without a definitive explanation. The tilt-table test is one diagnostic tool in that investigation, and its value is most realized when it is used after the cardiovascular causes of syncope (arrhythmia, structural disease) have been excluded and the clinical picture points to a reflex or autonomic mechanism.

From the clinical perspective, unexplained syncope is a high-priority finding for two reasons. First, because the differential includes potentially lethal arrhythmic causes that must be excluded before the diagnosis of vasovagal syncope is accepted. Second, because vasovagal syncope itself carries meaningful physical and psychological morbidity: falls with injury, driving restrictions, occupational limitations, and the chronic anxiety of not knowing when the next event will occur.

A structured cardiovascular assessment for a patient presenting with unexplained syncope follows a structured exclusion pathway: is there structural heart disease? Is there an arrhythmic cause documented on ECG or monitoring? Is there an orthostatic hemodynamic abnormality? Only after exclusion of these higher-priority diagnoses does reflex syncope management begin. The tilt-table test sits in that post-exclusion evaluation phase.

For patients with POTS, the cardiovascular workup goes beyond the tilt-table result to investigate the subtype: hypovolemic, neuropathic, hyperadrenergic, or autoimmune. Each subtype has a different treatment direction, and missing the autoimmune subtype in particular means missing a treatable underlying diagnosis that may respond to immunotherapy.

The practical management of vasovagal syncope, which is substantially lifestyle-driven, fits within a structured metabolic reset framework for patients who are ready to make behavioral changes, increase physical activity, and modify daily triggers systematically. For patients with recurrent syncope who are older and have documented asystole, the discussion about ILR monitoring and possible pacemaker therapy connects to PROC-016 (ICD and Pacemaker Implantation).

Tilt-table testing is available at Carle Foundation Hospital in Urbana-Champaign for patients across central Illinois. Complex POTS evaluation and autonomic function testing are available through the University of Illinois Health cardiac program and through specialist autonomic neurology services at Northwestern Medicine and Rush University Medical Center in Chicago.

Paired Foundations Articles:

• PROC-016: ICD and Pacemaker Implantation (cardioinhibitory vasovagal syncope and pacemaker selection)
• PROC-008: EP Study (arrhythmia exclusion before vasovagal diagnosis)
• PROC-013: Stress Testing (exertional syncope differentiation)
• PROC-015: Cardioversion (atrial fibrillation-related presyncope differentiation)

The Signal Check is fifteen questions mapping the cardiovascular risk pattern across the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.